Abstract
This month’s Oncology Scan focuses on 3 recent randomized trials that add to the growing literature on altered fractionation for women with early-stage breast cancer. The Danish and the Chinese experiences study moderate hypofractionation, in which whole breast radiation in the experimental arm is completed within 3 weeks. In each of these studies, hypofractionation proves to be no less effective than the more protracted traditional 5 weeks. Even more convenient is the British 5-fraction regimen, with treatment completed in 1 week. This month’s Oncology Scan summarizes these new trials and offers our perspective on their integration into modern practice.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International journal of radiation oncology, biology, physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
